Search terms
Results 1 - 2 of 2 - ordered by :

According to current clinical practice guidelines, prasugrel and ticagrelor have equal, Class I recommendations for use following percutaneous coronary intervention (PCI) in acute coronary syndromes ...

Date : 02/09/2019

The risk of death is highest in the first 6 months following myocardial infarction (MI).1,2 However, current ESC Guidelines recommend a delay of at least 6 weeks after MI before considering ...

Date : 04/09/2019